Sign in

CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company

BioRestorative Therapies, Inc.

Sign in to watch
Ticker
BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
301341024
Phone
(631) 760-8100
Business address
40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
Former names
Stem Cell Assurance, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-25 Silva Francisco VP of Research and Development Returned to the company · Stock Option −25,000 0
2019-03-25 Silva Francisco VP of Research and Development Grant or award · Stock Option +25,000 25,000
2019-03-25 Silva Francisco VP of Research and Development Returned to the company · Stock Option −60,000 0
2019-03-25 Silva Francisco VP of Research and Development Grant or award · Stock Option +60,000 60,000
2019-03-25 Silva Francisco VP of Research and Development Returned to the company · Stock Option −80,000 0
2019-03-25 Silva Francisco VP of Research and Development Grant or award · Stock Option +80,000 80,000
2019-03-25 Silva Francisco VP of Research and Development Returned to the company · Stock Option −100,000 0
2019-03-25 Silva Francisco VP of Research and Development Grant or award · Stock Option +100,000 100,000
2019-03-25 Paccasassi Robert VP, Quality and Compliance Returned to the company · Stock Option −5,000 0
2019-03-25 Paccasassi Robert VP, Quality and Compliance Grant or award · Stock Option +5,000 5,000
2019-03-25 Paccasassi Robert VP, Quality and Compliance Returned to the company · Stock Option −15,000 0
2019-03-25 Paccasassi Robert VP, Quality and Compliance Grant or award · Stock Option +15,000 15,000
2019-03-25 Paccasassi Robert VP, Quality and Compliance Returned to the company · Stock Option −40,000 0
2019-03-25 Paccasassi Robert VP, Quality and Compliance Grant or award · Stock Option +40,000 40,000
2019-03-25 Paccasassi Robert VP, Quality and Compliance Returned to the company · Stock Option −50,000 0
2019-03-25 Paccasassi Robert VP, Quality and Compliance Grant or award · Stock Option +50,000 50,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −4,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +4,000 4,000
2019-03-25 Weinreb Mark CEO and Chairman of the Board Returned to the company · Stock Option −50,000 0
2019-03-25 Weinreb Mark CEO and Chairman of the Board Grant or award · Stock Option +50,000 50,000

Page 17 of 35 · 690 trades